Development of tools to provide prioritisation and guidance in the development of chemical probes and small molecule leads

<p>Experimental methodological developments in measuring protein-ligand interactions for small molecule (<900 Da) drug discovery have led to an influx of data. In some instances this data overload has been overwhelming and can complicate rather than inform decision-making during drug di...